Translarna for Duchenne muscular dystrophy, patients already undergoing treatment can import the medicine from abroad at no cost to them

News Healthcare & Pharma Law & Policy Updates

Date: 17th Jun, 2025 Source: Italian Medicines Agency (AIFA) Country: Italy Original Source

Brief

"On 17/06/2025, the Italian Medicines Agency (AIFA) issued an update regarding Translarna for Duchenne muscular dystrophy. Patients already undergoing treatment can import the medicine from abroad at no cost to them, with costs covered by regional health services."

This content is restricted.

Highlights content goes here...

This content is restricted.

Italian Medicines Agency (AIFA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Translarna for Duchenne muscular dystrophy, patients already undergoing treatment can import the medicine from abroad at no cost to them

Brief

Italian Medicines Agency (AIFA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Translarna for Duchenne muscular dystrophy, patients already undergoing treatment can import the medicine from abroad at no cost to them

Brief

Italian Medicines Agency (AIFA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.